Anebulo Pharmaceuticals, Inc. (ANEB) stock
ANEBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.00+0.00 (+75.00%)
Close on Oct 19, 2026Market cap $28.76KP/E –Yield –
Anebulo Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Anebulo Pharmaceuticals's enterprise value was -$9.01M on Oct 19, 2026, against $96.84M a year earlier. Over the last 5 years it ranged from -$9.01M to $152.17M, with a median of $46.96M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | -$9.01M | -128.9% |
| 2025 | Dec 31, 2025 | $31.14M | -26.1% |
| 2024 | Dec 31, 2024 | $42.16M | -21.2% |
| 2023 | Dec 29, 2023 | $53.51M | +24.7% |
| 2022 | Dec 30, 2022 | $42.92M | -65.5% |
| 2021 | Dec 31, 2021 | $124.36M | – |
See a number that looks wrong?